Nano-Science Center > Research > Bionano and Nanomedicine > Martinez Group
Martinez
Group
The group of Karen L. Martinez explores
innovative interfaces of newly developed nano-tools with biological samples for
the development of novel biosensors to be used for pharmacological
investigation and diagnostics. Such new methods are developed in the
perspective of personalized medicine, providing well-suited therapies (better
efficiency and limited side effects). Emphasis is put on the exploitation of
sensitive membrane proteins because of their crucial roles in numerous
pathologies and the potential they represent for future therapies.
Click here for a more detailed description of our projects.
Please use the menu on the right to browse the pages for the Martinez Group >>>
